Certificate published for every lotSame-day dispatch before 1pm, Monday to FridayFree Royal Mail Tracked 48 over £75
ALTAResearch peptides
Home/Shop/Brain & Focus

Nootropic Peptides UK: Semax and Selank

Nootropic peptides from the Russian literature, supplied as lyophilised powder.

Semax research peptide vialNo. 015
Brain & FocusVial

Semax

ACTH(4-7)-Pro-Gly-Pro

Size
10 mg
HPLC
99.23%
Lot
R26042903
£21.99£2.20/mg
Selank research peptide vialNo. 016
Brain & FocusVial

Selank

Tuftsin-Pro-Gly-Pro

Size
10 mg
HPLC
≥99%
Lot
on request
£24.99£2.50/mg

Semax and Selank are heptapeptides developed at the Institute of Molecular Genetics in Moscow and in clinical use in Russia since 1994 and 2009 respectively. Semax is studied for attention, memory and BDNF expression; Selank for anxiolytic activity without sedation. Both are stocked as 10 mg lyophilised research vials. Finished nasal-spray versions sold as supplements are a different product from our sister brand, COGENT.

In brief: Nootropic peptides are short synthetic peptides studied for attention, memory and stress responses; the two with a clinical record are Semax and Selank. ALTA PEPTIDES stocks both as 10 mg lyophilised vials in UK stock, with the certificate of analysis published for Semax (lot R26042903), pending for Selank, dispatched the same working day before 1pm. Research use only.

The brain and focus range compared

CompoundMechanismSizePricePer mgCertificate
SemaxACTH(4-7)-Pro-Gly-ProACTH(4-10) analogue; neurotrophin up-regulation10 mg vial£21.99£2.20/mgLot R26042903 (manufacturer certificate)
SelankTuftsin-Pro-Gly-ProTuftsin analogue; GABAergic and immune modulation10 mg vial£24.99£2.50/mgPending

What the research covers

Semax, an ACTH(4-7) fragment with a Pro-Gly-Pro tail, has a larger human literature than most research peptides. A controlled study in healthy volunteers reported improved attention and short-term memory across an eight-hour shift after intranasal administration, which is the basis of its reputation among peptides for focus. Rodent studies show rapid increases in BDNF and TrkB expression in the hippocampus and activation of dopaminergic and serotonergic systems, without stimulant-like cardiovascular effects. It has been in clinical use in Russia since 1994 and is not licensed elsewhere.

Selank, a tuftsin analogue from the same institute, is the stress compound of the pair. Russian clinical studies in anxiety disorders report anxiolytic effects comparable to low-dose benzodiazepines without sedation, tolerance or withdrawal; mechanistic work points to GABAergic modulation and effects on serotonin and enkephalin metabolism. Rodent work uses the elevated plus maze and gene-expression readouts. There are no Western controlled trials. The Semax versus Selank article compares the two literatures.

Choosing between them

Semax for attention, learning and neurotrophin readouts; Selank for stress, anxiety-type behaviour and immune-cytokine designs. They share the Pro-Gly-Pro tail but have different parent fragments and different proposed mechanisms, which is why the stack builder offers them as the Focus pair at the 10% tier. DSIP in sleep pairs with Selank for HPA-axis designs. The vials here are lyophilised peptide for the laboratory; the finished Semax nasal spray sold as a supplement by our sister brand COGENT is a different product and is not what this page describes.

Buying in the UK

Semax and Selank are not controlled substances in the UK. Both are licensed medicines in Russia only; here they are unlicensed research chemicals, legal to buy and possess, sold for laboratory use and not for human use.

Everything on this page is held in UK stock and dispatched the same working day before 1pm Monday to Friday by Royal Mail Tracked 48 (£4.95, free over £75) in plain packaging. Certificates: published for Semax (lot R26042903), pending for Selank. That is the manufacturer's or supplier's paperwork published as received; ALTA's own independent test of each lot is added to the certificates page as it arrives. Any two of the single-compound vials here earn 10% off the peptide lines automatically, three earn 15% and four or more earn 20%; the stack builder shows the tiers.

Questions

Short peptides studied for effects on attention, memory, learning and stress responses. In practice the term means Semax and Selank, the two heptapeptides developed at the Institute of Molecular Genetics in Moscow, which are the only ones with a clinical record.

Semax is the one with a controlled human study of attention and short-term memory, plus rodent work on BDNF and TrkB. Selank is studied for anxiolytic activity rather than attention.

Yes. Neither is a controlled substance in the UK; both are licensed medicines in Russia only and are sold here as unlicensed research chemicals for laboratory use, not for human use.

Semax: the manufacturer's QC batch certificate for lot R26042903 is published on the certificates page, reporting purity 99.23% by HPLC. Selank: the certificate for the current lot is pending publication on the certificates page. ALTA's own independent third-party test of each lot is pending and is published on the same page as it arrives; no lot is described as independently tested until it is.

Guides for this category

Other research areas

Related: certificates of analysis, peptide calculator, build a stack, FAQ, all research peptides.

Research use only

Every product on this site is sold as a laboratory reagent for in-vitro and analytical research. Not for human or veterinary use, not a medicine, not a supplement. By ordering you confirm you are 18 or over and accept our research use policy.